Population pharmacokinetics of fedratinib in patients with myelofibrosis, polycythemia vera, and essential thrombocythemia
Crossref DOI link: https://doi.org/10.1007/s00280-019-03929-9
Published Online: 2019-08-23
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ogasawara, Ken http://orcid.org/0000-0002-4264-8927
Zhou, Simon
Krishna, Gopal
Palmisano, Maria
Li, Yan http://orcid.org/0000-0001-7609-2683
Text and Data Mining valid from 2019-08-23
Version of Record valid from 2019-08-23
Article History
Received: 13 June 2019
Accepted: 7 August 2019
First Online: 23 August 2019
Compliance with ethical standards
:
: KO, SZ, GK, MP and YL are employees and hold equity ownership in Celgene Corporation.